BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33377416)

  • 1. Management and Outcomes of Suspected Infectious and Inflammatory Lung Abnormalities Identified on Lung Cancer Screening CT.
    Mendoza DP; Chintanapakdee W; Zhang EW; Gilman MD; Lennes IT; Frank AJ; Shepard JO; Digumarthy SR
    AJR Am J Roentgenol; 2021 Nov; 217(5):1083-1092. PubMed ID: 33377416
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
    Mendoza DP; Petranovic M; Som A; Wu MY; Park EY; Zhang EW; Archer JM; McDermott S; Khandekar M; Lanuti M; Gainor JF; Lennes IT; Shepard JO; Digumarthy SR
    AJR Am J Roentgenol; 2022 Jul; 219(1):55-65. PubMed ID: 35080453
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency and distribution of incidental findings deemed appropriate for S modifier designation on low-dose CT in a lung cancer screening program.
    Reiter MJ; Nemesure A; Madu E; Reagan L; Plank A
    Lung Cancer; 2018 Jun; 120():1-6. PubMed ID: 29748003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Significant Coronary Artery Calcification Reported on Low-Dose Computed Tomography Lung Cancer Screening.
    Mendoza DP; Kako B; Digumarthy SR; Shepard JO; Little BP
    J Thorac Imaging; 2020 Mar; 35(2):129-135. PubMed ID: 31651689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive Procedures Associated With Lung Cancer Screening in Clinical Practice.
    Manyak A; Seaburg L; Bohreer K; Kirtland SH; Hubka M; Gerbino AJ
    Chest; 2023 Aug; 164(2):544-555. PubMed ID: 36781101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Cancer Screening CT: Sex-Specific Conversion Factors to Estimate Effective Radiation Dose From Dose-Length Product.
    Cohen SL; Wang JJ; Chan N; O'Connell W; Shah R; Sanelli P; Raoof S
    Chest; 2019 Dec; 156(6):1214-1222. PubMed ID: 31421112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial.
    Robbins HA; Katki HA; Cheung LC; Landy R; Berg CD
    J Thorac Oncol; 2019 Sep; 14(9):1662-1665. PubMed ID: 31125735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study.
    Perisinakis K; Seimenis I; Tzedakis A; Karantanas A; Damilakis J
    Eur Radiol; 2018 Oct; 28(10):4370-4378. PubMed ID: 29651767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Quick Reference Guide for Incidental Findings on Lung Cancer Screening CT Examinations.
    Dyer DS; White C; Conley Thomson C; Gieske MR; Kanne JP; Chiles C; Parker MS; Menchaca M; Wu CC; Kazerooni EA
    J Am Coll Radiol; 2023 Feb; 20(2):162-172. PubMed ID: 36509659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delays in Recommended Follow-Up after Positive Findings in Lung Cancer Screening.
    Ahmed A; Hippe DS; Snidarich M; Crothers K; Triplette M
    Ann Am Thorac Soc; 2023 Aug; 20(8):1175-1181. PubMed ID: 36973008
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
    Hadique S; Jain P; Hadi Y; Baig A; Parker JE
    BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
    Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
    Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and Clinician Recommendations to Improve Communication and Understanding of Lung Cancer Screening Results.
    Crothers K; Shahrir S; Kross EK; Kava CM; Cole A; Wenger D; Triplette M
    Chest; 2023 Mar; 163(3):707-718. PubMed ID: 36209835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
    Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
    J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardizing the Reporting of Incidental, Non-Lung Cancer (Category S) Findings Identified on Lung Cancer Screening Low-Dose CT Imaging.
    Tanoue LT; Sather P; Cortopassi I; Dicks D; Curtis A; Michaud G; Bader A; Gange C; Detterbeck F; Killam J
    Chest; 2022 Jun; 161(6):1697-1706. PubMed ID: 35032477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Positive and Suspicious Findings in Clinical Computed Tomography Lung Cancer Screening and the Road Ahead.
    Regis SM; Borondy-Kitts A; McKee AB; Rieger-Christ K; Sands J; Afnan J; McKee BJ
    Ann Am Thorac Soc; 2022 Aug; 19(8):1371-1378. PubMed ID: 34818144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.